CA
NZ
UK
AU
IND
US
Iovance Biotherapeutics Inc (NASDAQ:IOVA) climbed30.80% to $3.78 (February 24, 2026)as biotech investors rotated into oncology-focused growth names.
Clarivate Plc (NYSE:CLVT) surged39.88% to $2.35 (February 24, 2026), emerging as one of the top percentage gainers among US-listedmid-capstocks. The sharp rally has sparked investor interest in Clarivate’s financial health, turnaround strategy, and technical setup.
Vir Biotechnology Inc (NASDAQ:VIR) surged27.73% to $9.49 (February 24, 2026), driven by renewed biotech momentum and pipeline expectations.
USDC issuer triples Wall Street estimates with $770M revenue surge, yet entire profit model hangs on interest rates Powell may slash within months.
NVIDIA Corporation (NASDAQ:NVDA) ranked among the top NASDAQ volume gainers, with approximately175.12 million shares traded, translating to nearly$33.77 billion in traded value. The stock closed at$192.85, up0.68%, reflecting sustained institutional participation.
AMD surged8.77%to close at$213.84, with81.37 million shares tradedand relative volume of2.58, indicating strong institutional accumulation.
PLTR closed at$128.84, down1.35%, with47.12 million shares traded.Market capstands at$308.14 billion.
Tesla (NASDAQ:TSLA) advanced2.39%, closing at$409.38, with58.58 million shares tradedand approximately$23.98 billion in turnover. The stock remains one of the most actively traded names on NASDAQ.
HighlightsIntel shares climbed 5.71% on elevated volume, suggesting renewed investor interest as the company works through its multi-year turnaround strategy.Although trailing twelve-month EPS remains slightly negative at -$0.08, earnings trends show signs of stabilization, indicating that operational restructuring efforts may be gaining traction.Technically, the …
Artificial intelligence continues to command premium multiples across the stock market. Yet recent commentary from Wedbush introduces discipline into the prevailing narrative. While enterprise demonstrations from Anthropic reportedly impressed with workflow automation and reasoning capability, the broader claim that AI agents will imminently replace …
Please wait processing your request...